Summer is almost over. If you haven’t planned Fall advertising, you’re late! Let us do it. We handle everything. Talk to Undine McEvoy, email@example.com.
AGENDA RELEASED for 1st ever VIRTUAL Summit on Real World Evidence Needs and Practical Success Strategies: A Multi-Stakeholder Perspective on September 24, 2014? Register today (or sponsor/speak) Contact firstname.lastname@example.org.
|IN THIS ISSUE|
|SPOTLIGHT 1 OF THE WEEK||SPOTLIGHT 2 OF THE WEEK|
|Sticker Shock With Sovaldi – The Mass-Market Specialty Drug|
The new hepatitis C drug, Sovaldi, is not the most expensive drug on the market, so why is it getting so much negative feedback? This article is accompanied by charts explaining why Sovaldi is in a league of its own. (Source: The New York Times, 8/6/14).
Prisoners are the only group in America with a constitutional right to medical care, and with 17 percent of all inmates being infected with Hepatitis C, prisons are finding the budgetary impacts hard to justify. But will treating the active drug users in prison help get hepatitis C under control? (Source: The New York Times, 8/7/14).
What do patients want from health & social care? Do they want the same things? Abies Blog explores the idea of universal requirements: patients want to feel better, they want to feel better, and they want good service. Unfortunately what is measured today isn’t always what matters to patients. (Source: Abies Blog, 8/4/14).
Payers are now a significant player in product commercialization and companies need to rethink their business models. In this white paper we explore how the G-5 European countries have faced these challenges. (Source: eyeforpharma)
When one looks at all the new rules, regulations, fees, penalties, and requirements of insurance companies under the Affordable Care Act, one might begin to wonder how they will ever survive, and one MIGHT even begin to feel sorry for them, but are those feelings warranted? What does their bottom line say? (Source: The Hill, 8/6/14).
The Centers for Medicare & Medicaid Services (CMS) recently announced a minimal increase for 2015 Premiums for a basic Medicare Part D prescription drug plan, whereas Medicare Part B premiums are expected to stay the same. (Source: First Report Managed Care, 8/4/14).
The School of Health and Related Research (ScHARR) runs online open days for people who have applied, or are considering applying for postgraduate study at the School of Health and Related Research. Monday August 18, 2014 will be the open day for the MSc International Health Technology Assessment Pricing and Reimbursement course. (Source: The University of Sheffield, 2014).
|Link of the Week||Conference of the Week||Webinar of the Week|